SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-059819
Filing Date
2021-12-09
Accepted
2021-12-09 08:05:15
Documents
14
Period of Report
2021-12-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrtx-8k_20211209.htm   iXBRL 8-K 34662
2 EX-99.1 hrtx-ex991_62.htm EX-99.1 29414
3 GRAPHIC gxlehqfhd1gl000001.jpg GRAPHIC 2932
  Complete submission text file 0001564590-21-059819.txt   203800

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20211209.xsd EX-101.SCH 5681
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20211209_lab.xml EX-101.LAB 19339
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20211209_pre.xml EX-101.PRE 11487
7 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-8k_20211209_htm.xml XML 3557
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 211480314
SIC: 2834 Pharmaceutical Preparations